Association Between CD24-P226-C/T Polymorphism and Multiple Sclerosis: A Meta-Analysis

References

• Bai XF, Li O, Zhou Q, et al. (2004). CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis. J Exp Med, 200, 447–58
   PubMed Web of Science ®Google Scholar
• Bai XF, Liu JQ, Liu X, et al. (2000). The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis. Hepatology, 105, 1227–32
   Google Scholar
• Begg CB, Mazumdar M. (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088–101
   PubMed Web of Science ®Google Scholar
• Bjartmar C, Trapp BD. (2001). Axonal and neuronal degeneration in multiple sclerosis: Mechanisms and functional consequences. Curr Opin Neurol, 14, 271–8
   PubMed Web of Science ®Google Scholar
• Cui YZ, Xiao B, Zhou WB, et al. (2006). The association between the inducible costimulatory molecules, CD 28, CD24 gene polymorphisms and multiple sclerosis. Chin J Neurol, 39, 27–31
   Google Scholar
• Diaz-Gallo LM, Medrano LM, Gomez-Garcia M, et al. (2011). Analysis of the influence of two CD24 genetic variants in Crohn's disease and ulcerative colitis. Human Immunol, 72, 969–72
   PubMed Web of Science ®Google Scholar
• Dircio Delgado V, Plascencia-Alvarez N, Chima Galan MC, et al. (2009). CD24v polymorphism associated with clinical progression of multiple sclerosis in a patient group Centro Medico Nacional 20 de Noviembre, ISSSTE. Rev Mexi Neurosci, 10, 344–9
   Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. (1997). Bias in meta-analysis detected by a simple, graphical test. Br Med J, 315, 629–34
   PubMed Web of Science ®Google Scholar
• Figarella-Branger D, Moreau H, Pellissier JF, et al. (1993). CD24, a signal-transducing molecule expressed on human B lymphocytes, is a marker for human regenerating muscle. Acta Neuropathol, 86, 275–84
   PubMed Web of Science ®Google Scholar
• Gonzalez SJ, Rojas JI, Redal MA, et al. (2011). CD24 as a genetic modifier of disease progression in multiple sclerosis in Argentinean patients. J Neurol Sci, 307, 18–21
   PubMed Web of Science ®Google Scholar
• Gyu Song G, Ho Lee Y. (2013). CTLA-4 +49 A/G and −318 C/T polymorphisms and susceptibility to multiple sclerosis: A meta-analysis. Immunol Invest, 42, 409–22
   PubMed Web of Science ®Google Scholar
• Hough MR, Rosten PM, Sexton TL, et al. (1994). Mapping of CD24 and homologous sequences to multiple chromosomal loci. Genomics, 22, 154–61
   PubMed Web of Science ®Google Scholar
• Inoue N, Watanabe M, Hayashi F, et al. (2013). The association between a functional polymorphism in the CD24 gene and the development of autoimmune thyroid diseases. Tissue Antigens, 81, 161–3
   PubMed Web of Science ®Google Scholar
• Jevsek M, Jaworski A, Polo-Parada L, et al. (2006). CD24 is expressed by myofiber synaptic nuclei and regulates synaptic transmission. J Clin Invest, 103, 6374–9
   Google Scholar
• Kollaee A, Ghaffarpor M, Pourmahmoudian H, et al. (2011). Investigation of CD24 and its expression in Iranian relapsing-remitting multiple sclerosis. Int J Neurosci, 121, 684–90
   PubMed Web of Science ®Google Scholar
• Lisiansky V, Kraus S, Naumov I, et al. (2014). Role of CD24 polymorphisms in the susceptibility to inflammatory bowel disease. Int J Biol Markers, 29, e62–8
   PubMed Web of Science ®Google Scholar
• Otaegui D, Saenz A, Camano P, et al. (2006). CD24 V/V is an allele associated with the risk of developing multiple sclerosis in the Spanish population. Mult Scler, 12, 511–14
   PubMed Web of Science ®Google Scholar
• Piotrowski P, Lianeri M, Wudarski M, et al. (2010). CD24 Ala57Val gene polymorphism and the risk of systemic lupus erythematosus. Tissue Antigens, 75, 696–700
   PubMed Web of Science ®Google Scholar
• Poncet C, Frances V, Gristina R, et al. (1996). CD24, a glycosylphosphatidylinositol-anchored molecules is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors. Acta Neuropathol, 91, 400–8
   PubMed Web of Science ®Google Scholar
• Ronaghi M, Vallian S, Etemadifar M. (2009). CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population. Psych Res, 170, 271–2
   PubMed Web of Science ®Google Scholar
• Rueda B, Miranda-Filloy JA, Martin J, Gonzalez-Gay MA. (2008). Association of CD24 gene Polymorphisms with susceptibility to biopsy-proven giant cell arteritis. J Rheumatol, 35, 850–4
   PubMed Web of Science ®Google Scholar
• Sanchez E, Fernandez-Gutierrez B, Gonzalez-Gay MA, et al. (2008). Investigating the role of CD24 gene polymorphisms in rheumatoid arthritis. Ann Rheum Dise, 67, 1197–8
   PubMed Web of Science ®Google Scholar
• Song GG, Lee YH. (2014). A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility. Immunol Invest, 43, 299–311
   PubMed Web of Science ®Google Scholar
• Wang LZ, Lin SL, Rammohan KW, et al. (2007). A dinucleotide deletion in CD24 confers protection against autoimmune diseases. Plos Genet, 3, 508–17
   Google Scholar
• Yin YW, Zhang YD, Wang JZ, et al. (2012). Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: A meta-analysis of 6977 subjects. Gene, 511, 12–17
   PubMed Web of Science ®Google Scholar
• Zhou Q, Rammohan K, Lin S, et al. (2003). CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proc Natl Acad Sci USA, 100, 15041–6
   PubMed Web of Science ®Google Scholar
• Zuvich RL, McCauley JL, Pericak-Vance MA, Haines JL. (2009). Genetics and pathogenesis of multiple sclerosis. Semin Immunol, 21, 328–33
   PubMed Web of Science ®Google Scholar